TY - JOUR
T1 - The International Testicular Cancer Linkage Consortium
T2 - A clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred
AU - Mai, Phuong L.
AU - Friedlander, Michael
AU - Tucker, Kathy
AU - Phillips, Kelly-Anne
AU - Hogg, David
AU - Jewett, Michael A. S.
AU - Lohynska, Radka
AU - Daugaard, Gedske
AU - Richard, Stephane
AU - Bonaiti-Pellie, Catherine
AU - Heidenreich, Axel
AU - Albers, Peter
AU - Bodrogi, Istvan
AU - Geczi, Lajos
AU - Olah, Edith
AU - Daly, Peter A.
AU - Guilford, Parry
AU - Fossa, Sophie D.
AU - Heimdal, Ketil
AU - Liubchenko, Ludmila
AU - Tjulandin, Sergei A.
AU - Stoll, Hans
AU - Weber, Walter
AU - Easton, Douglas F.
AU - Dudakia, Darshna
AU - Huddart, Robert
AU - Stratton, Michael R.
AU - Einhorn, Lawrence
AU - Korde, Larissa
AU - Nathanson, Katherine L.
AU - Bishop, Timothy
AU - Rapley, Elizabeth A.
AU - Greene, Mark H.
PY - 2010
Y1 - 2010
N2 - Objectives: Familial aggregation of testicular germ cell tumor (TGCT) has been reported, but it is unclear if familial TGCT represents a unique entity with distinct clinicopathologic characteristics. Here we describe a collection of familial TGCT cases from an international consortium, in an effort to elucidate any clinical characteristics that are specific to this population.Materials and methods: Families with >= 2 cases of TGCT enrolled at 18 of the sites participating in the International Testicular Cancer Linkage Consortium were included. We analyzed clinicopathologic characteristics of 985 cases from 461 families.Results: A majority (88.5%) of families had only 2 cases of TGCT. Men with seminoma (50% of cases) had an older mean age at diagnosis than nonseminoma cases (P = 0.001). Among individuals with a history of cryptorchidism. TGCT was more likely to occur in the ipsilateral testis (kappa = 0.65). Cousin pairs appeared to represent a unique group, with younger age at diagnosis and a higher prevalence of cryptorchidism than other families.Conclusions: Clinicopathologic characteristics in these familial TGCT cases were similar to those generally described for nonfamilial eases. However, we observed a unique presentation of familial TGCT among cousin pairs. Additional studies are needed to further explore this observation. Published by Elsevier Inc.
AB - Objectives: Familial aggregation of testicular germ cell tumor (TGCT) has been reported, but it is unclear if familial TGCT represents a unique entity with distinct clinicopathologic characteristics. Here we describe a collection of familial TGCT cases from an international consortium, in an effort to elucidate any clinical characteristics that are specific to this population.Materials and methods: Families with >= 2 cases of TGCT enrolled at 18 of the sites participating in the International Testicular Cancer Linkage Consortium were included. We analyzed clinicopathologic characteristics of 985 cases from 461 families.Results: A majority (88.5%) of families had only 2 cases of TGCT. Men with seminoma (50% of cases) had an older mean age at diagnosis than nonseminoma cases (P = 0.001). Among individuals with a history of cryptorchidism. TGCT was more likely to occur in the ipsilateral testis (kappa = 0.65). Cousin pairs appeared to represent a unique group, with younger age at diagnosis and a higher prevalence of cryptorchidism than other families.Conclusions: Clinicopathologic characteristics in these familial TGCT cases were similar to those generally described for nonfamilial eases. However, we observed a unique presentation of familial TGCT among cousin pairs. Additional studies are needed to further explore this observation. Published by Elsevier Inc.
KW - Testicular neoplasms
KW - Familial
KW - Epidemiology
KW - Clinicopathologic characteristics
KW - OF-THE-LITERATURE
KW - SUSCEPTIBILITY GENES
KW - RISK-FACTORS
KW - EXPERIENCE
KW - ANTICIPATION
KW - EPIDEMIOLOGY
KW - POPULATION
KW - TESTIS
KW - FATHER
U2 - 10.1016/j.urolonc.2008.10.004
DO - 10.1016/j.urolonc.2008.10.004
M3 - Article
VL - 28
SP - 492
EP - 499
JO - Urologic Oncology-Seminars and Original Investigations
JF - Urologic Oncology-Seminars and Original Investigations
SN - 1078-1439
IS - 5
ER -